Product Information
MEDROXYPROGESTERONE 150 MG/ML is a generic product labeled by Xiromed LLC, priced at $18.8535 per ML under NDC 70700031527. Its NADAC has been published 60 times since Aug 13, 2025.
FDA first approved this application on Oct 12, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/mL
Manufacturer
Xiromed LLCNDC
70700031527
Classification
Generic
Dosage Form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
Effective Date
9/23/2026
Active Ingredients
MEDROXYPROGESTERONE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA210227FDA Approved
10/12/2018
TE Code
AB
On Market Since
3/12/2024
Pharmacological Classes
Price Statistics
The NADAC for MEDROXYPROGESTERONE 150 MG/ML has been published 60 times since Aug 13, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $18.8535 per ML |
|---|---|
| All-time high | $22.2984 (Dec 10, 2025) |
| All-time low | $18.3134 (Aug 19, 2026) |
| 52-week high | $22.2984 |
| 52-week low | $18.3134 |
| Median price | $20.2649 |
| Average price | $20.1716 |
| Largest weekly change | +8.0% (Oct 22, 2025) |
| Weeks tracked | 60 |
| Tracking since | Aug 13, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Xiromed LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Medroxyprogesterone Acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Progestin class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MEDROXYPROGESTERONE 150 MG/ML?
The current National Average Drug Acquisition Cost (NADAC) for MEDROXYPROGESTERONE 150 MG/ML, manufactured by Xiromed LLC, is $18.8535 per ML (NDC 70700031527), effective Sep 30, 2026.
How has the price of MEDROXYPROGESTERONE 150 MG/ML changed over time?
Over the history we have for it, the NADAC for MEDROXYPROGESTERONE 150 MG/ML has held within roughly two percent of its current level. It has been tracked across 60 weekly CMS publications since Aug 13, 2025.
What are the highest and lowest recorded NADAC prices for MEDROXYPROGESTERONE 150 MG/ML?
Since Aug 13, 2025, the NADAC for MEDROXYPROGESTERONE 150 MG/ML has ranged from a low of $18.3134 (Aug 19, 2026) to a high of $22.2984 (Dec 10, 2025), with a median of $20.2649 per ML.
Are there cheaper alternatives to MEDROXYPROGESTERONE 150 MG/ML?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MEDROXYPROGESTERONE 150 MG/ML, is $18.3134 per ML — about 3% below MEDROXYPROGESTERONE 150 MG/ML.
Who manufactures MEDROXYPROGESTERONE 150 MG/ML?
MEDROXYPROGESTERONE 150 MG/ML (NDC 70700031527) is labeled by Xiromed LLC, and CMS classifies it as a generic product.